1-20 of 22
S. Jagannath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Trial of SCIO-469 as Monotherapy (M) or in Combination with Bortezomib (MB) in Relapsed Refractory Multiple Myeloma (MM).

David S. Siegel, MD, PhD, A. Krishnan, MD, S. Lonial, MD, G. Chatta, MD, M. Alsina, MD, S. Jagannath, MD, P. Richardson, MD, R.J. Hohl, MD, J.A. Lust, MD, W. Bensinger, MD, G. Carrum, MD, J. Moreb, MD, A. Simic, MD, B. Barlogie, MD.PhD, R.T. Maziarz, MD, K.C. Anderson, MD, J. Lin, PhD, A. Lowe, MD, S. Vetticaden, MD, PhD, J. Zhu, MD
Journal: Blood
Blood (2006) 108 (11): 3580.
https://doi.org/10.1182/blood.V108.11.3580.3580
Published: 2006
Journal Articles

Lenalidomide Plus Bortezomib (Rev-Vel) in Relapsed and/or Refractory Multiple Myeloma (MM): Final Results of a Multicenter Phase 1 Trial.

Paul G. Richardson, MD, S. Jagannath, MD, D.E. Avigan, MD, M. Alsina, R.L. Schlossman, MD, A. Mazumder, MD, N.C. Munshi, MD, I. Ghobrial, MD, D. Doss, MD, M.L. McKenney, NP, M.G. Farrell, BS, D.L. Warren, BS, L.E. Lunde, BA, B. Gourley, BA, S. Vaccaro, BS, C. Delaney, BSN, S. Pountney, BS, C.S. Mitsiades, MD, PhD, T. Hideshima, MD, PhD, C. Byrne, RN, R. Knight, MD, A. Birner, Pharm D, T. Myers, MD, E. Weller, PhD, K.C. Anderson, MD
Journal: Blood
Blood (2006) 108 (11): 405.
https://doi.org/10.1182/blood.V108.11.405.405
Published: 2006
Journal Articles

A Phase 1 Trial of Lenalidomide (REVLIMID ® ) with Bortezomib (VELCADE ® ) in Relapsed and Refractory Multiple Myeloma.

Paul Richardson, R. Schlossman, N. Munshi, D. Avigan, S. Jagannath, M. Alsina, D. Doss, M. McKenney, K. Hande, M. Farrell, S. Gorelik, K. Colson, D. Warren, L. Lunde, R. Michelle, G. Cole, C. Mitsiades, T. Hideshima, T. Myers, R. Knight, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 365.
https://doi.org/10.1182/blood.V106.11.365.365
Published: 2005
Journal Articles

Safety and Efficacy of Bortezomib in Multiple Myeloma Patients with Renal Failure Requiring Dialysis.

Asher Alban Chanan-Khan, P. Richardson, S. Lonial, D. Siegel, S. Jagannath, J. Mehta, J. Doran, S. Singhal
Journal: Blood
Blood (2005) 106 (11): 2550.
https://doi.org/10.1182/blood.V106.11.2550.2550
Published: 2005
Journal Articles

Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

B. Barlogie, S. Jagannath, K.R. Desikan, S. Mattox, D. Vesole, D. Siegel, G. Tricot, N. Munshi, A. Fassas, S. Singhal, J. Mehta, E. Anaissie, D. Dhodapkar, S. Naucke, J. Cromer, J. Sawyer, J. Epstein, D. Spoon, D. Ayers, B. Cheson, J. Crowley
Journal: Blood
Blood (1999) 93 (1): 55–65.
https://doi.org/10.1182/blood.V93.1.55
Published: 1999
Journal Articles

Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple Myeloma

G. Tricot, Y. Gazitt, T. Leemhuis, S. Jagannath, K.R. Desikan, D. Siegel, A. Fassas, S. Tindle, J. Nelson, C. Juttner, A. Tsukamoto, J. Hallagan, K. Atkinson, C. Reading, R. Hoffman, B. Barlogie
Journal: Blood
Blood (1998) 91 (12): 4489–4495.
https://doi.org/10.1182/blood.V91.12.4489
Published: 1998
Journal Articles

Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell Transplantation

C.S. Zent, C.S. Wilson, G. Tricot, S. Jagannath, D. Siegel, K.R. Desikan, N. Munshi, D. Bracy, B. Barlogie, A.W. Butch
Journal: Blood
Blood (1998) 91 (9): 3518–3523.
https://doi.org/10.1182/blood.V91.9.3518
Published: 1998
Journal Articles

Autotransplants in multiple myeloma: what have we learned?

DH Vesole, G Tricot, S Jagannath, KR Desikan, D Siegel, D Bracy, L Miller, B Cheson, J Crowley, B Barlogie
Journal: Blood
Blood (1996) 88 (3): 838–847.
https://doi.org/10.1182/blood.V88.3.838.838
Published: 1996
Journal Articles

Graft-versus-myeloma effect: proof of principle

G Tricot, DH Vesole, S Jagannath, J Hilton, N Munshi, B Barlogie
Journal: Blood
Blood (1996) 87 (3): 1196–1198.
https://doi.org/10.1182/blood.V87.3.1196.bloodjournal8731196
Published: 1996
Journal Articles

Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor

Y Gazitt, E Tian, B Barlogie, CL Reading, DH Vesole, S Jagannath, J Schnell, R Hoffman, G Tricot
Journal: Blood
Blood (1996) 87 (2): 805–811.
https://doi.org/10.1182/blood.V87.2.805.bloodjournal872805
Published: 1996
Journal Articles

Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities

G Tricot, B Barlogie, S Jagannath, D Bracy, S Mattox, DH Vesole, S Naucke, JR Sawyer
Journal: Blood
Blood (1995) 86 (11): 4250–4256.
https://doi.org/10.1182/blood.V86.11.4250.bloodjournal86114250
Published: 1995
Journal Articles

Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells

Y Gazitt, CC Reading, R Hoffman, A Wickrema, DH Vesole, S Jagannath, J Condino, B Lee, B Barlogie, G Tricot
Journal: Blood
Blood (1995) 86 (1): 381–389.
https://doi.org/10.1182/blood.V86.1.381.bloodjournal861381
Published: 1995
Journal Articles

Enrichment of human hematopoietic stem cell activity in the CD34+Thy- 1+Lin- subpopulation from mobilized peripheral blood

L Murray, B Chen, A Galy, S Chen, R Tushinski, N Uchida, R Negrin, G Tricot, S Jagannath, D Vesole
Journal: Blood
Blood (1995) 85 (2): 368–378.
https://doi.org/10.1182/blood.V85.2.368.368
Published: 1995
Journal Articles

Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients

G Tricot, S Jagannath, D Vesole, J Nelson, S Tindle, L Miller, B Cheson, J Crowley, B Barlogie
Journal: Blood
Blood (1995) 85 (2): 588–596.
https://doi.org/10.1182/blood.V85.2.588.588
Published: 1995
Journal Articles

High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants

DH Vesole, B Barlogie, S Jagannath, B Cheson, G Tricot, R Alexanian, J Crowley
Journal: Blood
Blood (1994) 84 (3): 950–956.
https://doi.org/10.1182/blood.V84.3.950.950
Published: 1994
Journal Articles

Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support

S Jagannath, DH Vesole, L Glenn, J Crowley, B Barlogie
Journal: Blood
Blood (1992) 80 (7): 1666–1672.
https://doi.org/10.1182/blood.V80.7.1666.1666
Published: 1992
Journal Articles

Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy

WS Velasquez, LM Fuller, S Jagannath, SL Tucker, LB North, FB Hagemeister, P McLaughlin, F Swan, JR Redman, MA Rodriguez
Journal: Blood
Blood (1991) 77 (5): 942–947.
https://doi.org/10.1182/blood.V77.5.942.942
Published: 1991
Journal Articles

Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors

S Jagannath, B Barlogie, K Dicke, R Alexanian, G Zagars, B Cheson, FC Lemaistre, L Smallwood, K Pruitt, DO Dixon
Journal: Blood
Blood (1990) 76 (9): 1860–1866.
https://doi.org/10.1182/blood.V76.9.1860.1860
Published: 1990
Journal Articles

High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma

B Barlogie, S Jagannath, DO Dixon, B Cheson, L Smallwood, A Hendrickson, JD Purvis, E Bonnem, R Alexanian
Journal: Blood
Blood (1990) 76 (4): 677–680.
https://doi.org/10.1182/blood.V76.4.677.677
Published: 1990
Journal Articles

Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data

WS Velasquez, S Jagannath, SL Tucker, LM Fuller, LB North, JR Redman, F Swan, FB Hagemeister, P McLaughlin, F Cabanillas
Journal: Blood
Blood (1989) 74 (2): 551–557.
https://doi.org/10.1182/blood.V74.2.551.551
Published: 1989